EBSAM
AGN

Eubel Brady & Suttman Asset Management’s Allergan plc AGN Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-78,174
Closed -$14.9M – 84
2019
Q4 		$14.9M Sell
78,174
-4,308
-5% -$777K 3.99% 4
2019
Q3 		$13.9M Sell
82,482
-747
-0.9% -$122K 3.98% 6
2019
Q2 		$13.9M Buy
83,229
+1,551
+2% +$215K 3.91% 7
2019
Q1 		$12M Buy
81,678
+8,939
+12% +$1.3M 3.53% 10
2018
Q4 		$9.72M Sell
72,739
-5,803
-7% -$951K 3.18% 14
2018
Q3 		$15M Buy
78,542
+1,137
+1% +$209K 4.43% 5
2018
Q2 		$12.9M Sell
77,405
-233
-0.3% -$37.4K 3.99% 7
2018
Q1 		$13.1M Buy
77,638
+2,109
+3% +$354K 4.15% 6
2017
Q4 		$12.4M Buy
75,529
+20,983
+38% +$3.77M 3.68% 8
2017
Q3 		$11.2M Sell
54,546
-86
-0.2% -$20K 3.43% 13
2017
Q2 		$13.3M Buy
54,632
+212
+0.4% +$49.8K 4.05% 6
2017
Q1 		$13M Buy
54,420
+208
+0.4% +$48.4K 3.9% 7
2016
Q4 		$11.4M Buy
+54,212
New +$11.2M 3.42% 15
2015
Q2 		– Sell
-795
Closed -$237K – 86
2015
Q1 		$237K Buy
795
+10
+1% +$2.85K 0.07% 72
2014
Q4 		$202K Buy
+785
New +$196K 0.06% 74
2014
Q1 		– Sell
-1,684
Closed -$283K – 85
2013
Q4 		$283K Sell
1,684
-165
-9% -$25.8K 0.08% 65
2013
Q3 		$266K Sell
1,849
-16
-0.9% -$2.13K 0.07% 71
2013
Q2 		$235K Buy
+1,865
New +$211K 0.06% 75

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's AGN Position: Q1 2020 in Review

Eubel Brady & Suttman Asset Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 78,174 shares — an estimated $14.9M sold.

Eubel Brady & Suttman Asset Management first reported a position in AGN in Q2 2013 and held it in 18 quarters. The position peaked at $15M in Q3 2018. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Eubel Brady & Suttman Asset Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Eubel Brady & Suttman Asset Management sold 78,174 Allergan plc shares in Q1 2020, an estimated $14.9M.
  • Eubel Brady & Suttman Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 18 quarters.
  • Eubel Brady & Suttman Asset Management's Allergan plc position peaked at $15M in Q3 2018.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q1 2020, filed 13 May 2020.